• Home
  • PR

PR

News

게시물 상세
OliX Pharmaceuticals Signs Agreement with LGC Biosearch Technologies
Date : 2020-06-12     View : 906

 

OliX Pharmaceuticals Signs Agreement with LGC Biosearch Technologies to Accelerate Production of Asymmetric siRNA for the Treatment of Sub-Retinal Fibrosis and Wet Macular Degeneration 


Learn more: https://www.globenewswire.com/news-release/2020/06/16/2048913/0/en/OliX-Pharmaceuticals-Signs-Agreement-with-LGC-Biosearch-Technologies-to-Accelerate-Production-of-Asymmetric-siRNA-for-the-Treatment-of-Sub-Retinal-Fibrosis-and-Wet-Macular-Degenera.html


Source _ OliX Pharmaceuticals

Prev OliX Moves Into Spotlight Amid Strong RNAi Interest, New Platform
Next OliX Pharmaceuticals Expands Scientific Advisory Board with Addition of Leading Liver Experts